5 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow Endovascular Thrombectomy: new trials by email Literature Review of Endovascular Thrombectomy trials Research Report on Endovascular Thrombectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke OTR4132, Placebo - Endovascular Thrombectomy, Ischemic Cerebrovascular Accident | Phase 2 | Completed | Organ, Tissue, Regeneration, Repair and Replacement | 60 | 2025-03-14 | 2026-06-26 |
| Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation Tenecteplase, endovascular thrombectomy alone - Acute Ischemic Stroke, Intracranial Artery Occlusion | Phase 2 / Phase 3 | Completed | The First Affiliated Hospital of University of Science and Technology of China | 208 | 2023-01-24 | 2024-04-11 |
| Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol edaravone dexborneol - Stroke, Endovascular Thrombectomy | Phase 2 | Completed | Hui-Sheng Chen | 200 | 2021-02-23 | 2022-10-12 |
| Blood Pressure Management in Stroke Following Endovascular Treatment Labetalol, Hydralazine, Enalapril - Stroke, Acute, Vessels; Occlusion | Phase 2 | Completed | Hamilton Health Sciences Corporation | 30 | 2020-10-23 | 2023-11-07 |
| Blood Pressure After Endovascular Stroke Therapy-II Nicardipine, Labetalol, Hydralazine - Acute Stroke, Endovascular Thrombectomy | Phase 2 | Completed | University of Cincinnati | 120 | 2020-01-17 | 2023-10-12 |
Stroke (3) · Ischemic Stroke (2) · Bites and Stings (1) · Intracranial Hemorrhages (1)
Brain Diseases (5) · Cardiovascular Diseases (5) · Central Nervous System Diseases (5) · Cerebrovascular Disorders (5) · Nervous System Diseases (5) · Vascular Diseases (5) · Stroke (2) · Chemically-Induced Disorders (1) · Hemorrhage (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Poisoning (1) · Wounds and Injuries (1)
Hydralazine (2) · Labetalol (2) · Enalapril (1) · Nicardipine (1) · Tenecteplase (1)
Hamilton Health Sciences Corporation (1) · Hui-Sheng Chen (1) · Organ, Tissue, Regeneration, Repair and Replacement (1) · The First Affiliated Hospital of University of Science and Technology of China (1) · University of Cincinnati (1)
China (2) · Canada (1) · France (1) · United States (1)
Aristeidis H Katsanos, MD (1) · Eva Mistry, MBBS (1) · Olivier Detante, MD (1)
PMID 37668620, PMID 38124230, PMID 39809509, PMID 40064868, PMID 40674670, PMID 41583626
K23NS113858 (1)